Researchers at Tel Aviv University have developed a 2-in-1 anti-cancer nanoparticle. It is the world’ first RNA-based treatment to combine chemotherapy to destroy cancer cells and immunotherapy to stimulate the immune system to identify and attack the remaining cancer cells.
Cancer therapy “double-whammy”
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.